A Multicenter, Open-Label, Phase 1a/b First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BG-C477 in Patients with Selected Advanced Solid Tumors

Project: Research

Project Details

StatusActive
Effective start/end date11/10/24 → 11/10/26

Keywords

  • clinical trial
  • Advanced Solid Tumors
  • BG-C477

Clinical Trial Phase

  • Phase I